2.22
1.37%
0.03
Finanzdaten der Black Diamond Therapeutics Inc-Aktie (BDTX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
2.92%
20.25
|
20.86 | 24.01 | 20.03 | 21.56 |
Operating Income/Loss |
2.92%
-20.25
|
-20.86 | -24.01 | -20.03 | -21.56 |
Nonoperating Income/Loss |
39.67%
2.021
|
1.447 | 1.005 | 0.88 | 0.686 |
Income/Loss From Continuing Operations Before Tax |
6.10%
-18.23
|
-19.41 | -23.01 | -19.15 | -20.88 |
Income/Loss From Continuing Operations After Tax |
6.10%
-18.23
|
-19.41 | -23.01 | -19.15 | -20.88 |
Net Income/Loss
|
6.10%
-18.23
|
-19.41 | -23.01 | -19.15 | -20.88 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
1,902%
51.81
|
2.5873 | 50.94 | 36.52 | 36.48 |
Diluted Average Shares |
1,902%
51.81
|
2.5873 | 50.94 | 36.52 | 36.48 |
Basic Earnings Per Share |
2.94%
-0.35
|
-0.34 | -0.45 | -0.52 | -0.57 |
Diluted Earnings Per Share |
2.94%
-0.35
|
-0.34 | -0.45 | -0.52 | -0.57 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):